Anthony Aiudi Email & Phone Number

I have been part of the investment team at Morningside since 2020. I provide operational and managerial oversight and expertise to early-stage biotechnology companies, serving on the boards of several biotechnology companies across a broad spectrum of therapeutic areas. I have also facilitated company creation, completed multiple financings for private companies, and incubated portfolio companies. I completed a Fellowship in Clinical Research at Cubist Pharmaceuticals and Northeastern University, where I was also adjunct faculty. I later was a senior clinical research scientist at Merck & Co. From late 2015-2020, I was a director at Stealth BioTherapeutics, where I led the clinical development for numerous rare disease programs through their global Phase 3 program and supported the company through its IPO. I received my Pharm.D. and MBA from the University of Rhode Island and an M.S. in Finance from Northeastern University.

Listed skills include Medication Therapy Management, Community Pharmacy, Patient Counseling, Pharmacy Automation, and 4 others.